Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Sort descending Organization
Aug
25
2016
The Evolving Standard for Pleading Direct Patent Infringement Foley & Lardner LLP
May
30
2018
The Expanded Scope of the Printed Matter Doctrine and Effect on “Mental Steps” Brinks Gilson & Lione
Jan
19
2015
The Explicit Definition of a Claim Term Is Not Limiting Where It Excludes a Preferred Embodiment McDermott Will & Emery
Sep
3
2019
The Faithless Servant Doctrine: Can an Employer Claw Back Compensation from an Employee Who Binge-Watches “Friends” During Work Hours? Epstein Becker & Green, P.C.
Jul
24
2012
The Fate of the Music Industry is Jeopardized by Copyright Decision Dinsmore & Shohl LLP
Sep
6
2012
The FDA Proposes New Rule on Unique Medical Device Identification and Marking Requirements Faegre Drinker
Jul
21
2012
The FDA Safety and Innovation Act: Much More Than Just User Fees Barnes & Thornburg LLP
Jun
16
2011
The Federal Circuit Affirms the Delaware District Court’s Summary Judgment of Invalidity for Failure to Disclose the Best Mode Morgan, Lewis & Bockius LLP
Jan
24
2012
The Federal Circuit Agrees to Consider En Banc Whether Intervening Rights Can Apply To Independent Claims Not Amended During Reexamination Hunton Andrews Kurth
Jul
1
2015
The Federal Circuit Alters the Means-Plus-Function Analysis Mintz
Sep
30
2011
The Federal Circuit Applies Intervening Rights to Independent Claims Not Amended in Reexamination Hunton Andrews Kurth
Jun
6
2019
The Federal Circuit Applies Issue Preclusion to IPRs (And Further Calls Into Question Long-Standing Precedent Against Issue Preclusion In ITC Actions) Vedder Price
Jun
23
2020
The Federal Circuit Broadens Application of the Kessler Doctrine Mintz
Dec
2
2016
The Federal Circuit Confirms That It Will Review PTAB’s CBM Determinations … To A Certain Extent Mintz
Oct
9
2012
The Federal Circuit Continues to Make Inequitable Conduct More Difficult to Prove Sills Cummis & Gross P.C.
Feb
19
2019
The Federal Circuit Continues to Narrow the Eligibility Standards for CBM Review of Patents Under the AIA Squire Patton Boggs (US) LLP
Apr
6
2011
The Federal Circuit Court of Appeals Clarifies the Pleading Standard for False Patent Marking Claims Under 35 U.S.C. § 292 Michael Best & Friedrich LLP
Oct
20
2015
The Federal Circuit Declines To Revisit Its Decision That The Biosimilars Patent Dance Is Optional – Next Stop, Supreme Court? Squire Patton Boggs (US) LLP
Oct
30
2014
The Federal Circuit Denies Interlocutory Appeal in Licensing Dispute McDermott Will & Emery
Sep
5
2020
The Federal Circuit Expressly Declares that Juries Determine the Standard-Essentiality of Patent Claims Squire Patton Boggs (US) LLP
Aug
12
2020
The Federal Circuit Finds a “Hooke” to Patent Ineligibility Squire Patton Boggs (US) LLP
Nov
24
2012
The Federal Circuit Finds Declaratory Judgment Jurisdiction Exists Only with Immediacy and Reality McDermott Will & Emery
Nov
15
2012
The Federal Circuit Finds that Section 282 Is Not a Safety Net to Protect Against Failure to Disclosure Relevant Information During Discovery McDermott Will & Emery
Sep
2
2010
The Federal Circuit Holds That False Marking Plaintiff Has Standing to Sue in Stauffer v. Brooks Brothers Michael Best & Friedrich LLP
Mar
3
2013
The Federal Circuit Is Not the Place for Side Bets (Re: Patent Infringement Litigation) McDermott Will & Emery
Mar
11
2016
The Federal Circuit Newly Recognizes Patent-Agent Privilege Mintz
Feb
5
2019
The Federal Circuit Provides New Direction on Patent Term Adjustment Squire Patton Boggs (US) LLP
Apr
21
2021
The Federal Circuit Provides New Guidance for Patent Licensees Wishing to Challenge the Licensed Patent’s Validity Mintz
Feb
22
2021
The Federal Circuit Raises the Enablement Bar for Antibody Patents Polsinelli PC
Apr
22
2020
The Federal Circuit Reconsiders the Inherent Distinctiveness of Color Marks in In re Forney Sheppard, Mullin, Richter & Hampton LLP
Sep
1
2021
The Federal Circuit Rejects Infringement Arguments That Are Inconsistent with Prior Art Validity Arguments Finnegan
Jul
30
2014
The Federal Circuit Reverse a Finding of Anticipation of the PTAB in Inter Partes Review McDermott Will & Emery
Feb
26
2018
The Federal Circuit Reverses and Vacates Invalidity Determinations by the Board After Lack of Substantial Evidence Supported the Board’s Findings Hunton Andrews Kurth
Feb
26
2018
The Federal Circuit Reverses and Vacates the District Court’s Dismissal Under Rule 12(b)(6), for not Considering Allegations of Fact That Could Preclude Dismissal Hunton Andrews Kurth
May
31
2013
The Federal Circuit Reverses Summary Judgment that Reissue Patent Claims Were Not Obvious McDermott Will & Emery
Jul
24
2018
The Federal Circuit Shuts the Door on Use of Tribal Immunity in IPRs Squire Patton Boggs (US) LLP
Feb
20
2020
The Federal Circuit Takes a Mulligan and Reins in the Eastern District of Texas’s Assertion of Venue the Second Time Around Squire Patton Boggs (US) LLP
Aug
28
2012
The Federal Circuit Will Decide if a Damages Trial or Decision on Willfulness Is Required Before a Judgment of Patent Infringement Can Be Appealed Sills Cummis & Gross P.C.
Mar
31
2018
The Federal Circuit Will Decide Whether Sovereign Immunity Can be Used to Escape Patent Invalidation by the PTAB – If the Supreme Court Finds Inter Partes Review Constitutional Squire Patton Boggs (US) LLP
Jun
4
2015
The Federal Circuit’s First Foray into the BPCIA: “A Pulitzer Prize for Complexity”? Mintz
Feb
14
2020
The Federal Circuit’s Polaris Decision Provides Insights Into The Constitutionality Of Inter Partes Reviews Cadwalader, Wickersham & Taft LLP
Oct
28
2011
The Federal Circuit’s Recent Reexamination Rulings Hunton Andrews Kurth
Sep
22
2012
The Federal Circuit’s Recent “Safe Harbor” Ruling Could Impact Biosimilars Drug Development Faegre Drinker
Jan
24
2017
The Federal Circuit’s Standing Requirement to Appeal Patent Office Decisions Proskauer Rose LLP
Jul
21
2016
The Federal Defend Trade Secrets Act vs. The California Uniform Trade Secrets Act Sheppard, Mullin, Richter & Hampton LLP
Sep
19
2022
The Federal Trade Commission’s Five-Year Strategic Plan Unsurprisingly Includes a Focus on Noncompetes Epstein Becker & Green, P.C.
Feb
4
2015
The Fight Against Counterfeit Products in Canada Just Got Easier Dickinson Wright PLLC
Jan
28
2021
The Fight Continues: Being Prepared for Additional Litigation Following the Issuance of an International Trade Commission Exclusion Vedder Price
Jan
24
2023
The Fight for Red: Fashion Statement or Protected Trademark? Stark & Stark
Jul
8
2012
The Final Curtain Call? Not Quite Yet New Standard of Review for Willfulness McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins